Friday, July 21, 2017 10:38:46 AM
DOW JONES & COMPANY, INC. 12:31 AM ET 7/21/2017
The following table shows the largest shareholders in BIO PATH HOLDINGS INC COM (BPTH) for the quarter ended June 30, 2017, listed by holding size. The list represents up to 50 of the largest holders in the company.
Note: Unless otherwise mentioned the reporting date is 06/30/2017
Institution Shares Shares % Last
Held Changed Held Report
University of Texas Investment 3,830,882 0 4.005 03/31
BlackRock Fund Advisors 3,493,327 (43,068) 3.652 03/31
The Vanguard Group Inc. 2,912,516 15,808 3.045 03/31
HighTower Advisors LLC 1,263,070 105,000 1.321 03/31
SSgA Funds Management Inc. 1,130,406 45,732 1.182 03/31
Northern Trust Investments In 885,208 34,765 0.926 03/31
Raymond James Financial Servic 773,806 0 0.809 03/31
Geode Capital Management LLC 688,183 5,706 0.720 03/31
Sabby Capital LLC 687,398 23,352 0.719 03/31
Commonwealth Equity Services 374,398 (12,269) 0.391 03/31
BlackRock Investment Managemen 312,285 (1,478) 0.327 03/31
The Bank of New York Mellon Co 257,529 0 0.269 03/31
Millennium Management LLC 257,229 (251,568) 0.269 03/31
TIAA-CREF Investment Managemen 251,861 (8,429) 0.263 03/31
WFG Advisors LP 205,136 0 0.214 03/31
California State Teachers' Ret 181,738 (400) 0.190 03/31
Teachers Advisors LLC 149,324 0 0.156 03/31
Charles Schwab Investment Mana 131,200 0 0.137 03/31
Tower Research Capital LLC 126,699 126,699 0.132 03/31
The California Public Employee 115,900 0 0.121 03/31
Morgan Stanley & Co. LLC 115,741 (141,809) 0.121 03/31
RhumbLine Advisers Ltd. Partne 101,201 23,723 0.106 03/31
Creative Planning Inc. 100,000 20,000 0.105 06/30
New York State Common Retireme 85,301 1 0.089 03/31
Wells Fargo Bank NA (Private 66,300 38,300 0.069 03/31
JPMorgan Securities LLC (Inves 59,389 (61,280) 0.062 03/31
Nationwide Fund Advisors 52,318 0 0.055 03/31
SunAmerica Asset Management LL 51,376 3,620 0.054 03/31
BlackRock Advisors LLC 49,387 0 0.052 03/31
Mellon Capital Management Corp 48,944 0 0.051 03/31
Ironwood Investment Counsel LL 44,674 0 0.047 03/31
Voya Investment Management Co. 44,232 0 0.046 03/31
Legal & General Investment Man 31,821 0 0.033 03/31
Deutsche Asset Management Inve 21,680 (26,500) 0.023 03/31
Principal Global Investors LLC 20,520 20,520 0.021 03/31
Goldman Sachs & Co. LLC (Priva 16,170 1,933 0.017 03/31
Bank of America NA (Private B 15,682 3,525 0.016 03/31
Credit Suisse Securities (USA) 13,570 (20,239) 0.014 03/31
Amalgamated Bank 10,817 (28) 0.011 03/31
ProShare Advisors LLC 10,185 (4,028) 0.011 03/31
Wells Fargo Clearing Services 8,500 0 0.009 03/31
Ameritas Investment Partners 6,471 6,471 0.007 03/31
BNY Mellon Capital Markets LLC 5,172 5,172 0.005 03/31
Wells Fargo Advisors Financial 5,000 0 0.005 03/31
Meeder Asset Management Inc. 3,763 0 0.004 06/30
RBC Dominion Securities Inc. 3,462 (2,130) 0.004 03/31
BlackRock Financial Management 3,188 0 0.003 03/31
UBS Securities LLC 2,373 (14,768) 0.002 03/31
Deutsche Bank Securities Inc. 1,352 (1,905) 0.001 03/31
PanAgora Asset Management Inc 1,206 1,206 0.001 03/31
Recent BPTH News
- Bio-Path Holdings, Inc. Announces Closing of $1.2 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules • GlobeNewswire Inc. • 04/19/2024 04:14:04 PM
- Bio-Path Holdings, Inc. Announces $1.2 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules • GlobeNewswire Inc. • 04/18/2024 05:57:59 PM
- Bio-Path Holdings Announces Successful Completion of Higher Dose Second Cohort in Phase 1/1b Clinical Trial of BP1002 in Refractory/Relapsed Acute Myeloid Leukemia (AML) Patients • GlobeNewswire Inc. • 04/18/2024 11:00:00 AM
- Bio-Path Holdings Expands Global Patent Portfolio • GlobeNewswire Inc. • 04/15/2024 11:00:00 AM
- Bio-Path Holdings Provides 2024 Clinical and Operational Update • GlobeNewswire Inc. • 04/02/2024 11:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/11/2024 11:00:34 AM
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 03/08/2024 10:11:50 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/08/2024 12:10:34 PM
- Bio-Path Holdings Reports Full Year 2023 Financial Results • GlobeNewswire Inc. • 03/08/2024 12:00:00 PM
- U.S. Index Futures Fluctuate Ahead of Key Jobs Report; Oil Prices Dip • IH Market News • 03/08/2024 11:22:25 AM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/07/2024 09:21:27 PM
- Bio-Path Holdings to Announce Fourth Quarter and Full Year 2023 Financial Results on March 8, 2024 • GlobeNewswire Inc. • 03/01/2024 12:00:00 PM
- Form RW - Registration Withdrawal Request • Edgar (US Regulatory) • 02/29/2024 11:00:30 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/23/2024 12:01:09 PM
- Bio-Path Holdings Announces 1-for-20 Reverse Stock Split • GlobeNewswire Inc. • 02/21/2024 12:00:00 PM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 02/02/2024 09:39:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/02/2024 09:10:23 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/23/2024 10:20:23 PM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 01/23/2024 09:51:03 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 01/17/2024 09:52:48 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/10/2024 09:10:09 PM
- Bio-Path Holdings Announces Completion of First Dose Cohort in Phase 1 Clinical Trial Evaluating BP1002 to Treat Refractory/Relapsed Lymphoma and Refractory/Relapsed Chronic Lymphocytic Leukemia Patients • GlobeNewswire Inc. • 01/10/2024 12:00:00 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 01/04/2024 10:18:53 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 12/22/2023 09:06:16 PM
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 12/22/2023 09:05:51 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM